Amedeo's Top 20

Amedeo Smart

Independent Medical Education

03 February 2014

Multidisciplinary Journal Club

  1. Churchyard GJ, Fielding KL, Lewis JJ, Coetzee L, et al.
    A trial of mass isoniazid preventive therapy for tuberculosis control.
    N Engl J Med 2014;370:301-10.

  1. Doody RS, Thomas RG, Farlow M, Iwatsubo T, et al.
    Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
    N Engl J Med 2014;370:311-21.

  2. Haibe-Kains B, El-Hachem N, Birkbak NJ, Jin AC, et al.
    Inconsistency in large pharmacogenomic studies.
    Nature 2013;504:389-93.

  3. Pietersen E, Ignatius E, Streicher EM, Mastrapa B, et al.
    Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study.
    Lancet 2014.

  4. Uyeki TM.
    Preventing and Controlling Influenza with Available Interventions.
    N Engl J Med 2014.

  1. Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, et al.
    PI3Kdelta Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma.
    N Engl J Med 2014.

  2. Santantonio T, Fasano M, Sagnelli E, Tundo P, et al.
    Acute hepatitis C: A 24 week-course of Peg-Interferon alpha-2b versus a 12 week-course of Peg-Interferon alpha-2b alone or with ribavirin.
    Hepatology 2014.

  3. Rowe CC, Bourgeat P, Ellis KA, Brown B, et al.
    Predicting Alzheimer disease with beta-amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing.
    Ann Neurol 2013;74:905-13.

  4. Herpertz-Dahlmann B, Schwarte R, Krei M, Egberts K, et al.
    Day-patient treatment after short inpatient care versus continued inpatient treatment in adolescents with anorexia nervosa (ANDI): a multicentre, randomised, open-label, non-inferiority trial.
    Lancet 2014.

  5. Sapisochin G, de Lope CR, Gastaca M, de Urbina JO, et al.
    Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver Transplantation: A Spanish Matched Cohort Multicenter Study.
    Ann Surg 2014.

  1. Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, et al.
    Warfarin Use and the Risk for Stroke and Bleeding in Patients with Atrial Fibrillation Undergoing Dialysis.
    Circulation 2014.

  2. Bruhn CA, Audelin AM, Helleberg M, Bjorn-Mortensen K, et al.
    The origin and emergence of an HIV-1 epidemic: from introduction to endemicity.
    AIDS 2014.

  3. Zuliani AC, Barros Esteves SC, Teixeira LC, Teixeira JC, et al.
    Concomitant Cisplatin Plus Radiotherapy and High-Dose-Rate Brachytherapy Versus Radiotherapy Alone for Stage IIIB Epidermoid Cervical Cancer: A Randomized Controlled Trial.
    J Clin Oncol 2014.

  4. Drukker CA, van Tinteren H, Schmidt MK, Rutgers EJ, et al.
    Long-term impact of the 70-gene signature on breast cancer outcome.
    Breast Cancer Res Treat 2014.

  5. Mwafongo A, Nkanaunena K, Zheng Y, Hogg E, et al.
    Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine: analysis from the AIDS Clinical Trial Group A5208 trial.
    AIDS 2014.

  1. Fuchs CS, Tomasek J, Yong CJ, Dumitru F, et al.
    Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
    Lancet 2014;383:31-9.

  2. Bingham CO 3rd, Rizzo W, Kivitz A, Hassanali A, et al.
    Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA).
    Ann Rheum Dis 2014.

  3. Emery P, Gottenberg JE, Rubbert-Roth A, Sarzi-Puttini P, et al.
    Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study.
    Ann Rheum Dis 2014.

  4. Pena C, Suarez C, Ocampo-Sosa A, Murillas J, et al.
    Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohort.
    Clin Infect Dis 2013;57:208-16.

  5. Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, et al.
    Clinical and biological implications of driver mutations in myelodysplastic syndromes.
    Blood 2013;122:3616-27; quiz 3.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016